ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$209.41
Tradestie Score
65
Market Cap
$431.71B
P/E Ratio
103.3
Revenue Growth
0.1%
Analyst Upside
+20.4%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$228.92
|
$448.07B | 26.7 | 63 | Compare |
|
NVO
Novo-Nordisk A/S
|
$44.28
|
$262.92B | 10.4 | 57 | Compare |
|
AZN
AstraZeneca PLC
|
$183.92
|
$261.56B | 27.2 | 54 | Compare |
|
NVS
Novartis AG
|
$149.15
|
$254.99B | 21.4 | 60 | Compare |
|
ABT
Abbott Laboratories
|
$87.91
|
$232.30B | 23.8 | 61 | Compare |
|
MRK
Merck & Co., Inc.
|
$112.56
|
$225.13B | 31.9 | 56 | Compare |
|
AMGN
Amgen Inc
|
$324.39
|
$160.70B | 23.4 | 57 | Compare |
|
PFE
Pfizer Inc.
|
$25.33
|
$154.70B | 19.7 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$129.67
|
$137.92B | 17.9 | 61 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.54
|
$121.27B | 18.6 | 53 | Compare |
More ABBV Analysis
Data updated: May 18, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry